“…Of the 58 included studies, Randomised Control Trial (RCT) was the most common study design ( n = 27, 46.6%), [ 35 , 37 – 39 , 43 – 45 , 52 , 54 – 56 , 58 , 59 , 61 , 65 , 69 – 73 , 79 – 81 , 95 – 97 ] followed by pre-post ( n = 11, 19.0%) [ 50 , 60 , 63 , 64 , 66 , 77 , 78 , 86 , 98 – 101 ]. Study design of remaining studies included cohort (retrospective and prospective) ( n = 7, 12.1%), [ 34 , 36 , 47 , 48 , 83 – 85 , 88 ] single arm trial ( n = 6, 10.3%), [ 40 , 41 , 46 , 67 , 82 , 89 , 92 , 102 , 103 ] case study ( n = 3, 5.2%), [ 57 , 104 , 105 ] pseudo-RCT ( n = 2, 3.4%), [ 42 , 51 ] non-inferiority trial ( n = 1, 1.7%) and qualitative ( n = 1, 1.7%) [ 49 , 76 ]. Study designs were categorised according to the NHMRC Evidence Hierarchy as level II ( n = 27, 46.6%), level III study ( n = 28, 50.9%), level IV ( n = 14, 24.2%) or not at all ( n = 1, 1.7%) see Additional files 3 and 5 ) [ 35 , 37 – 39 , 43 –…”